Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/4/2018
SIETES contiene 92261 citas

 
 
 1 a 20 de 4208 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Benefits NL, Pipe A, West R, Hays JT, Tonstad S, McRae T, Lawrence D, St Aubin L, Anthenelli RM. Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers. A randomized clinical trial. JAMA Intern Med 2018:9 de abril. [Ref.ID 102506]
2. Cita con resumen
Anónimo. Outbreak Alert: Potential life-threatening vitamin K-dependent antagonist coagulopathy associated with synthetic cannabinoids use. Centers for Disease Control and Prevention 2018:5 de abril. [Ref.ID 102503]
3. Cita con resumen
4.Enlace a cita originalTiene citas relacionadas Cita con resumen
Olfson M, Wall MM, Liu SM, Blanco C. Cannabis use and risk of prescription opioid use disorder in the United States. Am J Psychiatry 2018;175:enero. [Ref.ID 102495]
5.Enlace a cita originalTiene citas relacionadas Cita con resumen
Wen H, Hockenberry JM. Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees . JAMA Intern Med 2018:2 de abril. [Ref.ID 102494]
6.Enlace a cita originalTiene citas relacionadas Cita con resumen
Bradford AC, Bradford WD, Abraham A, Bagwell Adams G. Association between US state medical cannabis laws and opioid prescribing in the Medicare Part D population. JAMA Intern Med 2018:2 de abril. [Ref.ID 102493]
7.Enlace a cita originalTiene citas relacionadas Cita con resumen
Hill KP, Saxon AJ. The role of cannabis legalization in the opioid crisis. JAMA Intern Med 2018:2 de abril. [Ref.ID 102492]
9. Cita con resumen
Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants — United States, 2015–2016. Morbidity and Mortality Weekly Report 2018;67:30 de marzo. [Ref.ID 102488]
10. Cita con resumen
The editors. FDA advisers recommend approval of non-opioid drug for opioid withdrawal. Physician's First Watch 2018:4. [Ref.ID 102485]
12. Cita con resumen
Branswell H. Salmonella outbreak in 20 states linked to kratom consumption. STAT 2018:3. [Ref.ID 102462]
14. Cita con resumen
Mir de Francia R. Los fabricantes de opioides fijan a España como nuevo mercado. eldiario.es 2018:1. [Ref.ID 102452]
15.
Whitlock J. Cannabis-derived drug granted priority review. San Diego Business Journal 2018:2 de enero. [Ref.ID 102441]
17. Cita con resumen
Peckham AM, Fairman KA, Sclar DA. Call for increased pharmacovigilance of gabapentin. BMJ 2017;359:j5456. [Ref.ID 102156]
18.Tiene citas relacionadas Cita con resumen
Kyriacou DN. Opioid vs nonopioid acute pain management in the emergency department. JAMA 2017;318:1655-6. [Ref.ID 102136]
19.Tiene citas relacionadas Cita con resumen
O'Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden M. Deaths involving fentanyl, fentanyl analogs, and U-47700 — 10 states, July–December 2016. Morbidity and Mortality Weekly Report 2017;66:1-5. [Ref.ID 102103]
20. Cita con resumen
Eiden C, Mathieu O, Donnadieu-Rigole H, Marrot C, Peyrière H. High opioids tolerance due to transmucosal fentanyl abuse. Eur J Clin Pharmacol 2017;73:1195-6. [Ref.ID 102078]
Seleccionar todas
 
 1 a 20 de 4208 siguiente >>